Fund Companies Rights Offerings Managed Distributions Leveraged Funds IPOs Asset Classes CEF Advisors

My Fund Comparison
Initilizing list...

NexPoint Healthcare Opportunities Fund; Class Z Shares  as of 08/27/2018

N/A / N/A Asset Class:  Sector Equity Funds 1 YR Lipper Avg:  N/A*

Growth of $10K

Avg Annual Total Return %
  10 YR 5 YR 1 YR YTD
Market Return -- -- -- --
Lipper Pct. Rank -- -- -- --
NAV Return -- -- -- --
Lipper Pct. Rank -- -- -- --

NAV $19.35 Market Price --
Net Change $0.13 Market Change --
Premium/Discount --
1 YR NAV Return --
1 YR NAV Rank --
12-Mo Yield as of -- Yield Def
Income Only Yield 0.00%
Distribution Yield (Market) --
Most Recent Income Dividend --
Ex-Div Date --
Most Recent Cap Gain Dividend --
Ex-Div Date --
Dividend Frequency Quarterly
YTD Dividends --
YTD Capital Gains --
Inception Date 5/29/2018
Fund Advisor NexPoint Advisors LP
Manager & Tenure Dondero since 2018
Hilgenbrink since 2018
Burns since 2018
Phone 844-485-9167
Website --
Total Net Assets (mil) as of -- --
% Leveraged Assets as of -- --
Portfolio Turnover --
Mgmt Fees --
Expense Ratio --
Fund Objective
The Fund seeks total return consisting of current income and longer-term capital appreciation. It invests, under normal circumstances, at least 80% of its total assets (net assets plus the amount of any borrowing for investment purposes) in the securities of U.S. and non-U.S. companies engaged in the healthcare industry.


*1 YR Lipper Average not available for this fund.



Resources


Aberdeen Closed-End TV

Asset TV — CEF Channel

CEF Connect

Cohen & Steers CEFs Knowledge Center

Harvest — CEFA Channel

Legg Mason CEFs

Seeking Alpha — CEFA Channel


SySys Logo

Lipper Logo
Powered by a SySys data & content management system.

© Thomson Reuters 2011. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.